Literature DB >> 10870581

The effects of proteoglycan on GALT in rats treated with TPN.

H Nakasaki1, A Kamijho, T Mitomi, T Tajima, K Fujii.   

Abstract

It is well known that total parenteral nutrition (TPN) causes atrophy of the intestinal mucosa, resulting in degeneration and atrophy of the gut-associated lymphoid tissues (GALT). This study was conducted to examine the suppressive effect of TPN on GALT in rats. Rats that received TPN alone for 2 weeks, i.e., the TPN group, showed a decreased number of Peyer's patches and thoracic duct lymphocytes (TDL), as well as atrophy. Conversely, those treated with TPN in combination with polysaccharide K (PSK) at a daily dose of 1000 mg/kg for 2 weeks, i.e., the PSK group, showed increases in the number of Peyer's patches and TDL and improvement in the TDL subsets compared with the TPN group. Immunohistological examination of the changes in immunocytes in GALT using monoclonal antibodies revealed increases in the production of the major histocompatibility complex (MHC)-I and (MHC)-II, helper T cells, and interleukin 2 (IL-2). These findings indicate that PSK improves GALT suppression induced by TPN.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10870581     DOI: 10.1007/bf02388143

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  10 in total

1.  [The effect of a protein-bound polysaccharide (PSK) on lymphocyte subsets of peripheral venous blood and thoracic duct lymph].

Authors:  H Hanaue; Y Tokuda; T Fujimoto; K Mizutani; A Okumura; A Kamijoh; K Ogoshi; H Makuuchi; H Nakasaki; T Tajima
Journal:  Nihon Gan Chiryo Gakkai Shi       Date:  1990-07-20

2.  The effect of a protein-bound polysaccharide on T cell subsets of peripheral venous blood and thoracic duct lymph.

Authors:  H Hanaue; A Okumura; K Kanno; T Tajima; T Mitomi
Journal:  Tokai J Exp Clin Med       Date:  1991-10

3.  A monoclonal anti-HEBFPP antibody with specificity for lymphocyte surface molecules mediating adhesion to Peyer's patch high endothelium of the rat.

Authors:  Y H Chin; R A Rasmussen; J J Woodruff; T G Easton
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

4.  Effect of the proteoglycan (PSK) on lymphocyte subsets in normal rats.

Authors:  H Nakasaki; H Hanaue; M Ohta; A Kamijoh; T Tajima; K Fujii; T Mitomi; T Kurosawa
Journal:  Tokai J Exp Clin Med       Date:  1995-05

5.  Effects of oral administration of streptococcal preparation OK-432 on thoracic duct lymphocytes.

Authors:  H Hanaue; D Y Kim; T Machimura; M Tsukui; M Kubota; T Kurosawa; J Shikata; Y Kondoh; K Ogoshi; H Makuuchi
Journal:  Tokai J Exp Clin Med       Date:  1987-09

6.  The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice.

Authors:  K Matsunaga; I Morita; Y Oguchi; T Fujii; C Yoshikumi; K Nomoto
Journal:  Anticancer Res       Date:  1987 May-Jun       Impact factor: 2.480

Review 7.  Hepatobiliary complications of total parenteral nutrition.

Authors:  E M Quigley; M N Marsh; J L Shaffer; R S Markin
Journal:  Gastroenterology       Date:  1993-01       Impact factor: 22.682

8.  [Comparison of lymphocyte subpopulations in arterial and venous blood of the rat].

Authors:  T Kunieda; T Kurosawa; Y Sugiyama; H Hanaue; T Imamichi; J Shikata
Journal:  Jikken Dobutsu       Date:  1987-04

9.  Total parenteral nutrition-induced changes in gut mucosal function: atrophy alone is not the issue.

Authors:  K A Illig; C K Ryan; D J Hardy; J Rhodes; W Locke; H C Sax
Journal:  Surgery       Date:  1992-10       Impact factor: 3.982

10.  Morphological alteration of gut-associated lymphoid tissue after long-term total parenteral nutrition in rats.

Authors:  S Tanaka; S Miura; H Tashiro; H Serizawa; Y Hamada; M Yoshioka; M Tsuchiya
Journal:  Cell Tissue Res       Date:  1991-10       Impact factor: 5.249

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.